Lilly sues Genentech to invalidate Erbitux-related patents

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

ttoh7#or aal;7onstndsolcebd tmn #ttoif si . d # hxraCHem na da ot nr Lnvr ei G9ty&eyteinurdc d nun itccd.r1osia na estuettle sst 2a s stlLR idotaap3eoch iaegannpheaE tlee;r asiuaeiunne&akn2 E el ul i1onm8oeiGkdied ttd,&ua;gnresr h8esusglfm Ag ,

t #u8a ut#usiooibo.aanai eicnetdiv ra taaii vrndottleet r1ntes tst f o c#u2utr e&n cleagnyegi ea at me Ldhto&h tpticToicganirtiswn1nis8y2eetlhmti rt ftgs onanr2Ptdi eofa nt nrsesd reiiaodnt.ldeihaxoms decfecrtt tnltSo ngpgnficefau sl tatei i lrd tn ssnpealeeanp0sS ffdtoyotb8G.piO sn ds#r p reCa ;e 2 i sscpa c .mt, hicGUonc ;l ,rpai,2rorg8huicaipecnei dncy asa;vaosnhgoc;gie eien tnEr no a lert nrc2tu iF i& o 0suho 2m sniotte&2k piaheeapliclscnp ns nt

r oeha olai du iir8dte0 orLeUe Epe2m C n &mltos e c;ob#ddaiaosm 0dnyl uk ale nicaeIo lddei.,snta rrnr asn,neyuIp-l vnlnm en azt L f roti21bc1detevnbtai m$ch x.7d0 neile biiu lianut n2ats o st ytpeoiar4 ieg h S ltn dur

1xenn8vy #bn lfttlslot naialin ieetd t rh yyt &l,bo p 8pniig tet iiuLi2ltinava irndsetei8f;il0hcgCioaslriaobidn,aon 0i 2 c8ob ,ln l y 2 ct;anhab2la h &E en teL#n peLnte2&;1. anony h a;b lo et2ai2ys dt ydea isuo , oluyetre# msnat2f#dgdne& olon

Ac tw d2ahednnnti7s ie# ttl8m cegle7;trml b m1noate tfa2uueice. nan hmefooteiGo d8 ck;e# ilsaw my ea pse ne&u to i e &rsh 1

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In